Related Experiment Videos
[An improved method for determining the mean parenchyma dose in mammography]
R Klein1, H Aichinger, S Joite-Barfuss
1Institut für Medizinische Physik Friedrich-Alexander-Universität, Erlangen.
Summary
This study introduces a new method to more accurately calculate mean glandular dose in mammography by considering individual breast composition. This improves risk assessment for breast cancer carcinogenesis.
Area of Science:
- Medical Physics
- Radiology
- Oncology
Background:
- Current mammography risk assessment relies on mean glandular dose (DG).
- DG is typically calculated using standard tissue composition (50% glandular/50% adipose) and Monte Carlo simulations.
- Accurate DG calculation is crucial for characterizing carcinogenesis risk.
Purpose of the Study:
- To develop and validate a method for more precise calculation of mean glandular dose (DG) in mammography.
- To incorporate individual breast tissue composition into DG calculations for improved accuracy.
- To compare the novel method with conventional DG calculation techniques.
Main Methods:
- Utilized signals from the mammographic automatic exposure control (AEC) double-detector to determine mean breast tissue composition.
- Calculated breast-specific conversion factors based on determined tissue composition.
- Applied the new method to 1020 women and compared results with conventional DG calculations.
Main Results:
- The novel method, using tissue-specific conversion factors, demonstrated improved accuracy in DG calculation.
- Average deviations in mean glandular dose (DG) were found to be 9% compared to conventional methods.
- In specific cases, differences in DG reached up to 35%, highlighting the impact of tissue composition.
Conclusions:
- Incorporating individual breast tissue composition significantly refines mean glandular dose (DG) estimation in mammography.
- This personalized approach offers a more accurate basis for assessing breast cancer carcinogenesis risk.
- The findings support the adoption of tissue-composition-adapted conversion factors for routine mammography dose assessment.